Expressive Writing for Depression and Anxiety
(EWMS Trial)
Trial Summary
What is the purpose of this trial?
Sexual minority stressors (e.g., sexual minority identity-based discrimination) contribute to greater risk for and severity of depression, anxiety, substance use disorders and suicide among sexual minority Veterans. However, no brief, scalable, one-on-one interventions targeting sexual minority stressor-related distress are available in Veterans Affairs (VA) for sexual minority Veterans. The proposed research will examine the feasibility, acceptability, and preliminary effectiveness of a brief, 3-session expressive writing intervention to target distress related to sexual minority stressor exposure among sexual minority Veterans. The results of this work will advance knowledge about a promising brief and easy to implement intervention focused on reducing depressive and anxiety symptoms among sexual minority Veterans. This proposal aligns with VA's and CSR\&D's commitment to providing equitable services to sexual minority Veterans and the aim of reducing health disparities among underserved Veteran groups.
Do I need to stop my current medications to join the trial?
The trial requires that participants be stable on their psychotropic medication for at least 4 weeks, so you do not need to stop taking your current medications if they are stable.
What data supports the effectiveness of the treatment Expressive Writing for Depression and Anxiety?
Is expressive writing safe for humans?
How does the treatment Expressive Writing for Minority Stressors differ from other treatments for depression and anxiety?
Expressive Writing for Minority Stressors is unique because it involves writing about personal experiences related to minority stress, which can help reduce depression and anxiety by allowing individuals to process and express their emotions. Unlike traditional therapies that may involve direct interaction with a therapist, this treatment can be done privately and may be particularly beneficial for those who are socially inhibited or prefer not to engage in face-to-face therapy.910111213
Research Team
Kelly L Harper, PhD
Principal Investigator
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Eligibility Criteria
This trial is for sexual minority Veterans experiencing significant depression or anxiety, who have faced discrimination due to their sexuality. They must score above 10 on specific mental health scales and identify as non-heterosexual. Those with severe substance use disorders, cognitive impairments, suicidal plans/intent, or unstable mania/psychosis cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 3-session expressive writing intervention targeting distress related to sexual minority stressors
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Expressive Writing on Minority Stressors (Behavioural Intervention)
- Neutral Writing (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor